We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Reasonable Alternative to Biopsy of Palpable Breast Lesions with Benign Imaging Characteristics Evaluated

By MedImaging International staff writers
Posted on 22 Dec 2009
Short-term follow-up is a practical alternative to invasive biopsy of palpable breast lesions with benign imaging features, especially in younger women with probable fibroadenoma (non-cancerous tumors that frequently occur in women during their reproductive years), according to recent research.

The study, published in the December 2009 issue of the American Journal of Roentgenology (AJR), was performed at the University of Virginia (Charlottesville, VA, USA), and consisted of a group of 320 women with 375 palpable masses with benign features for which short-term follow-up was recommended. "We found that only one case of cancer was diagnosed for which short-term follow-up had been recommended,” said Jennifer A. Harvey, M.D., lead author of the study.

"Our study of palpable breast lesions with benign features showed an acceptably low prevalence of breast cancer--low that short-term follow-up is a reasonable alternative to biopsy,” continued Dr. Harvey. "Application of the results of our study may reduce the number of biopsies that result in benign findings. There is also significant cost savings associated with using short-term follow-up rather than immediate biopsy.” 

Related Links:

University of Virginia


Medical Radiographic X-Ray Machine
TR30N HF
Digital X-Ray Detector Panel
Acuity G4
X-Ray Illuminator
X-Ray Viewbox Illuminators
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.